The overexpression of ABC transporters in cancer cells accelerates the efflux of chemotherapeutic drugs, resulting in cancer drug resistance, recurrence and ultimately death in cancer patients (Gillet and Gottesman, 2010; Wu et al., 2011). Here, ABCG2 is linked to cancer.